Evotec SE (FRA:EVT)

Germany flag Germany · Delayed Price · Currency is EUR
6.53
+0.10 (1.59%)
Last updated: Aug 14, 2025
1.59%
Market Cap1.14B
Revenue (ttm)777.33M
Net Income (ttm)-155.53M
Shares Outn/a
EPS (ttm)-0.88
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume169,862
Average Volume1,671,752
Open6.51
Previous Close6.43
Day's Range6.42 - 6.56
52-Week Range5.06 - 10.62
Betan/a
RSI39.45
Earnings DateAug 13, 2025

About Evotec SE

Evotec SE operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally. It operates in two segments, Shared R&D and Just – Evotec Biologics. The company is developing pharmaceutical products in various therapeutic areas, such as oncology, autoimmune, cancer, diabetes, heart failure, immunology, pain and inflammation, infectious, kidney, liver, respiratory, fibrotic and metabolic disease, and rare diseases; central nervous system (CNS) and cardiometabolic disease... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1993
Employees 4,740
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol EVT
Full Company Profile

Financial Performance

In 2024, Evotec SE's revenue was 796.97 million, an increase of 1.99% compared to the previous year's 781.43 million. Losses were -196.08 million, 133.7% more than in 2023.

Financial Statements

News

Evotec SE reports 1H results

1 day ago - Seeking Alpha

Earnings Scheduled For August 13, 2025

Companies Reporting Before The Bell • Evotec (NASDAQ: EVO) is projected to report quarterly loss at $0.12 per share on revenue of $238.88 million. • Elbit Systems (NASDAQ: ESLT) is projected to repo...

1 day ago - Benzinga

Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution

Strategy for sustainable profitable growth progressing as planned with improving revenue mix and ahead-of-plan cost reductionsReporting segment formerly known as Shared R&D renamed to Discovery & Prec...

1 day ago - Wallstreet:Online

Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution

Strategy for sustainable profitable growth progressing as planned with improving revenue mix and ahead-of-plan cost reductions Reporting segment formerly known as Shared R&D renamed to Discovery & Pre...

1 day ago - Accesswire

Evotec SE's H1 2025 Results: Strategy Execution Shines Brightly

Evotec SE navigates a mixed financial landscape in H1 2025, balancing revenue dips with strategic advancements and promising growth in biologics. Jetzt den vollständigen Artikel lesen

1 day ago - Wallstreet:Online

EQS-News: Evotec SE reports H1 2025 results: Strong progress on strategy execution

EQS-News: Evotec SE / Key word(s): Half Year Report/Half Year Results Evotec SE reports H1 2025 results: Strong progress on strategy execution 13.08.2025 / 07:00 CET/CEST The issuer is solely responsi...

1 day ago - Wallstreet:Online

An Overview of Evotec's Earnings

Evotec (NASDAQ: EVO) is gearing up to announce its quarterly earnings on Wednesday, 2025-08-13. Here's a quick overview of what investors should know before the release. Analysts are estimating that ...

2 days ago - Benzinga

Evotec SE to announce first half-year results 2025 on 13 August 2025

HAMBURG, DE / ACCESS Newswire / August 6, 2025 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) will announce its half-year interim r...

8 days ago - Wallstreet:Online

Evotec SE to announce first half-year results 2025 on 13 August 2025

HAMBURG, DE / ACCESS Newswire / August 6, 2025 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, Prime Standard, ISIN: DE0005664809, WKN 566480; NASDAQ:EVO) will announce its half-year interim r...

8 days ago - Accesswire

EQS-News: Evotec SE to announce first half-year results 2025 on 13 August 2025

EQS-News: Evotec SE / Key word(s): Half Year Results Evotec SE to announce first half-year results 2025 on 13 August 2025 06.08.2025 / 09:52 CET/CEST The issuer is solely responsible for the content o...

8 days ago - Wallstreet:Online

Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site

HAMBURG, DE / ACCESS Newswire / July 30, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces the signing of a non-bin...

15 days ago - Wallstreet:Online

Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site

HAMBURG, DE / ACCESS Newswire / July 30, 2025 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:EVO) announces the signing of a non-bin...

15 days ago - Accesswire

Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site

Evotec SE and Sandoz AG signed a non-binding term sheet on a planned sale of Just - Evotec Biologics EU in Toulouse to SandozUnder the proposed deal Evotec would transfer biosimilar manufacturing capa...

15 days ago - Wallstreet:Online

Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site

Evotec SE and Sandoz AG signed a non-binding term sheet on a planned sale of Just - Evotec Biologics EU in Toulouse to Sandoz Under the proposed deal Evotec would transfer biosimilar manufacturing cap...

15 days ago - Accesswire

EQS-News: Evotec and Sandoz evolve their strategic partnership and agree on potential sale of Just – Evotec Biologics Toulouse site

EQS-News: Evotec SE / Key word(s): Agreement Evotec and Sandoz evolve their strategic partnership and agree on potential sale of Just – Evotec Biologics Toulouse site 30.07.2025 / 07:16 CET/CEST The i...

15 days ago - Wallstreet:Online

EQS-Adhoc: Evotec SE and Sandoz AG planning potential sale of Just – Evotec Biologics Toulouse site

EQS-Ad-hoc: Evotec SE / Key word(s): Agreement Evotec SE and Sandoz AG planning potential sale of Just – Evotec Biologics Toulouse site 30-Jul-2025 / 07:14 CET/CEST Disclosure of an inside information...

15 days ago - Wallstreet:Online

EQS-PVR: Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: Evotec SE Evotec SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 23.07.202...

22 days ago - Wallstreet:Online

Evotec: Recovery Seems To Be Beginning

22 days ago - Seeking Alpha

Evotec, Webull And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Monday. Shares of Evotec SE (NASDAQ: EVO) fell sharply in pre-market trading after the company updated i...

24 days ago - Benzinga

Evotec, Webull And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Monday.

24 days ago - Benzinga

Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix

Successful execution of new strategy for sustainable and profitable growth leading to changing revenue mix with strong demand for Evotec's differentiated platformsHigh-margin technology license revenu...

24 days ago - Wallstreet:Online

Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix

Successful execution of new strategy for sustainable and profitable growth leading to changing revenue mix with strong demand for Evotec's differentiated platforms High-margin technology license reven...

24 days ago - Accesswire